ZEOMBUS
LIVE

Serial Number

79208581

Owner

NOVARTIS AG

Filing Date

Apr 7, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ZEOMBUS Trademark

Serial Number: 79208581 • Registration: 5298904

ZEOMBUS is a trademark filed by NOVARTIS AG on April 7, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 7, 2017

Registration Date

October 3, 2017

Published for Opposition

July 18, 2017

Cancellation Date

April 27, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Dec 6, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Dec 6, 2021 DETH
NOTIFICATION PROCESSED BY IB
Jan 26, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Nov 20, 2017 FICS
FINAL DISPOSITION PROCESSED
Nov 20, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 2, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 3, 2017 R.PR
PUBLISHED FOR OPPOSITION
Jul 18, 2017 PUBO
NOTICE OF PUBLICATION
Jun 28, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2017 CNSA
APPLICATION FILING RECEIPT MAILED
Jun 6, 2017 MAFR
ASSIGNED TO EXAMINER
Jun 2, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 31, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 30, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
May 27, 2017 SDRC